U.S. Real Estate Stock News

Cardinal Health (CAH) just delivered quarterly earnings that topped profit expectations, prompting management to lift full year adjusted EPS guidance, even as revenue shortfalls, pricing pressure and impairment charges kept investor attention on execution. See our latest analysis for Cardinal Health. At a share price of US$195.24, Cardinal Health has retreated with a 30 day share price return of 8.79% and a 90 day share price return of 10.44%, even as repeated earnings beats, raised guidance...

Wondering whether BXP at around US$59.37 is offering value or just value traps? This article breaks down what the current price might really mean for you. The stock has recently shown mixed returns, with a 2.3% gain over the last week and 14.7% over the last month, set against a year to date return of a 12.5% decline and a 1 year return of a 3.8% decline. Over the longer term, the picture is uneven, with a 37.9% gain across 3 years contrasted by a 29.0% decline over 5 years. This can leave...

In April 2026, Target Hospitality Corp. completed a follow-on equity offering of 7,000,000 common shares, raising approximately US$98,000,000 at US$14 per share with a US$0.735 discount per share. This fresh equity capital, raised through a sizeable common stock issuance, has implications for existing shareholders, future funding flexibility, and the company’s long-term capital structure. Next, we’ll examine how this US$98,000,000 equity raise may reshape Target Hospitality’s investment...

Planet Labs PBC recently launched three additional Pelican satellites, including the first under a satellite services agreement with the Swedish Armed Forces, and separately announced plans to design a SWIR-only Tanager spacecraft with Carbon Mapper and Jet Propulsion Laboratory to enhance environmental monitoring capabilities. These moves highlight Planet’s push into higher-value defense and climate applications, pairing rapid sovereign satellite deployment with more specialized, AI-enabled...

Crypto and blockchain are back in focus as investors look for assets that can handle higher energy costs, sticky inflation risks, and shifting central bank plans. With AI-related demand supporting parts of global trade and payment systems under pressure from geopolitical tension, the broader digital infrastructure story is still evolving. The Top Cryptocurrency and Blockchain Stocks screener cuts through the noise by highlighting companies directly linked to this theme, without relying on...

Summit Therapeutics (SMMT) has drawn intense attention after its stock dropped sharply following updates that its key Phase III ivonescimab trial will continue without an early efficacy signal, alongside wider first quarter losses and a flagged going concern risk. See our latest analysis for Summit Therapeutics. The latest Q1 loss and going concern warning have triggered a sharp reset in sentiment, with a 1-day share price return of -24.91% and a 7-day share price return of -27.15%. This has...

Xcel Energy stock snapshot after recent performance Xcel Energy (XEL) has drawn attention after a recent mix of short term and longer term returns, with the stock last closing at $82.58 and posting a 0.4% decline over the past day. See our latest analysis for Xcel Energy. That small one-day share price pullback comes after stronger momentum in recent months, with a 90-day share price return of 8.7% and a one-year total shareholder return of 20.2%, which hints at gradually improving sentiment...

Cohu (COHU) gave investors fresh data to work with after first quarter 2026 results, combining higher semiconductor test demand tied to AI and high performance computing with updated guidance and a larger opportunity pipeline. See our latest analysis for Cohu. Those stronger AI and high performance computing headlines have arrived alongside a sharp re-rating, with an 85.25% year to date share price return and a very large 1 year total shareholder return, even after a recent 3.72% 1 day...

Sherwin-Williams (SHW) just delivered Q1 2026 results that came in ahead of expectations, reaffirmed its full year outlook and highlighted its new zero-VOC Emerald Symmetry paint as a sustainability-focused product launch. See our latest analysis for Sherwin-Williams. The stock has softened in recent weeks, with a 7 day share price return of 5.39% and a 90 day share price return of an 11.58% decline. However, the 3 year total shareholder return is 41.41%, suggesting longer term holders are...

Recent price action and business snapshot Maase (MAAS) has drawn investor attention after a 63% share price move over the past month and 58% over the past 3 months, prompting a closer look at its current fundamentals. The company provides technological intelligence and capital investment services in China through a technology-driven independent financial service platform and independent wealth management services. It reports revenue of CN¥3.483 and a net loss of CN¥1.775. See our latest...

Event driven snapshot of Liberty Latin America Liberty Latin America (LILA) has drawn fresh attention after recent trading, with the stock last closing at $8.25 and showing a mixed pattern of short term returns over the past week and month. See our latest analysis for Liberty Latin America. The 1 day share price return of 1.60% and 7 day share price return of 1.23% sit against a year to date share price return of 13.64% and a 1 year total shareholder return of 56.84%. This suggests momentum...

In recent days, Manchester United’s short-term focus on Champions League qualification has coincided with uncertainty around key injuries, transfer rumours involving players such as Manuel Ugarte and Rafael Leao, and continued debate over whether Michael Carrick or Andoni Iraola will take the permanent manager role. Beyond the immediate football implications, this mix of managerial speculation and potential high-profile squad turnover signals a period of meaningful change in how the club may...

Sector-driven move in Allegro MicroSystems Allegro MicroSystems (ALGM) climbed 6.0% during a broad semiconductor rally, as renewed interest in chip stocks lifted the sector and drew stronger trading activity into Allegro’s shares. See our latest analysis for Allegro MicroSystems. That 6.0% move sits within a strong upswing, with a 30-day share price return of 50.25% and a year-to-date share price return of 82.01%. The 1-year total shareholder return stands at 155.77%. If semiconductor...

Caterpillar Inc. ( NYSE:CAT ) investors will be delighted, with the company turning in some strong numbers with its...

Some Meta Platforms, Inc. ( NASDAQ:META ) shareholders may be a little concerned to see that the Chief Operating...

As you might know, DT Midstream, Inc. ( NYSE:DTM ) just kicked off its latest quarterly results with some very strong...

The Cigna Group ( NYSE:CI ) came out with its first-quarter results last week, and we wanted to see how the business is...

As you might know, Stryker Corporation ( NYSE:SYK ) last week released its latest first-quarter, and things did not...

TowneBank ( NASDAQ:TOWN ) shareholders (or potential shareholders) will be happy to see that insider J. Perry recently...

At its April 17, 2026 Technology Open Day, Hesai Group unveiled its Picasso 6D full-color lidar chip and ETX lidar series, which combine geometry and color sensing on a single ASIC and are targeted for L3-plus autonomous driving with mass production planned in the second half of 2026. The move into a broader “spatial intelligence” platform, spanning automotive, robotics, and embodied AI, positions Hesai to supply sensing hardware across a wide range of future Physical AI applications. We’ll...

In April 2026, Charles River Laboratories International launched an enhanced in vitro fertility (IVF) service bundle for rat models, combining embryo transfer, cryopreservation, and colony rederivation to help research teams accelerate preclinical programs across oncology, neurology, cardiology, and metabolic disease while easing breeding bottlenecks. This IVF expansion deepens the company’s Genetically Engineered Model Services offering, highlighting how specialized reproductive...

In late April 2026, Arlo Technologies reported Q4 2025 results that surpassed analyst expectations on earnings per share and revenue, while its CFO Kurtis Joseph Binder sold US$146,077 of stock under a pre-arranged Rule 10b5-1 plan. At the same time, Arlo’s Board authorized a US$50 million share repurchase program through December 31, 2027, signaling management’s confidence in the company’s outlook even as insiders have been net sellers in recent months. Next, we’ll examine how Arlo’s...

BeOne Medicines (ONC) has drawn fresh attention after the FDA granted Priority Review to a supplemental Biologics License Application for TEVIMBRA with ZIIHERA and chemotherapy in advanced HER2-positive gastroesophageal cancers, alongside a global HH160 collaboration. See our latest analysis for BeOne Medicines. Despite the FDA Priority Review for TEVIMBRA and the new HH160 collaboration, the share price return has softened recently. The 30-day share price return is 5.45% and the 90-day share...

Recent performance snapshot for GRAIL (GRAL) GRAIL (GRAL) has traded around US$54.06 at the latest close, with the stock showing a 1 day return of about a 1% decline and a 7 day return of roughly a 2% decline. Over the past month, the stock’s return is near a 2% decline, while the past 3 months show a deeper move of about a 49% decline, setting a very different picture from its reported 1 year total return of about 58%. See our latest analysis for GRAIL. The recent share price weakness,...